BioSpace News Archive

Press Releases

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026

February 26, 2026
·
19 min read
Press Releases

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

February 26, 2026
·
20 min read
Press Releases

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

February 26, 2026
·
9 min read
Press Releases

Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy

February 26, 2026
·
12 min read
Press Releases

Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1

February 26, 2026
·
6 min read
Press Releases

ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing

February 26, 2026
·
6 min read
Press Releases

ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen

February 26, 2026
·
4 min read
Press Releases

Chemed Reports Fourth-Quarter 2025 Results

February 26, 2026
·
27 min read
Press Releases

NANOBIOTIX to Participate in Investor Conferences in March 2026

February 26, 2026
·
2 min read
Press Releases

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

February 26, 2026
·
18 min read